ADJUVANT TARGET DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES.

NIH RePORTER · NIH · N43 · $600,000 · view on reporter.nih.gov ↗

Abstract

Using their unique Membrane Proteome Array (MPA)technology, the contractor will screen a comprehensive library of human cell surface proteins to identify novel immunomodulatory targets that regulate dendritic cell or Toll-like receptor (TLR) activation.

Key facts

NIH application ID: 10678504
Project number: 75N93022C00032-0-9999-1
Recipient: INTEGRAL MOLECULAR
Principal Investigator: JOSEPH RUCKER
Activity code: N43
Funding institute: NIH
Fiscal year: 2022
Award amount: $600,000
Award type: —
Project period: 2022-06-30 → 2024-06-29